Search | IOVS | ARVO Journals

Showing 1 – 20 of 23

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Efficacy of Intravitreal Aflibercept Treat-and-Extend Regimen Over 2 Years for Neovascular Age-Related Macular Degeneration: ARIES Study

Eric H Souied; Frank G. Holz; Philip G Hykin; Edoardo Midena; Sebastian Wolf; Helmut Allmeier; Paul Mitchell

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4210.

ARVO Annual Meeting Abstract June 2020

Comparison of treat-and-extend (T&E) dosing regimens and visual outcomes in the ARIES and ALTAIR studies of intravitreal aflibercept (IVT-AFL) in neovascular age-related macular degeneration (nAMD)

Paul Mitchell; Frank G. Holz; Philip G Hykin; Edoardo Midena; Annabelle A Okada; Eric H Souied; Kanji Takahashi; Sebastian Wolf; Helmut Allmeier; George Lambrou; Thomas Schmelter; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4219.

ARVO Annual Meeting Abstract July 2019

Treatment response based on topography of retinal neovascularization in proliferative diabetic retinopathy

Sandra Halim; Amy A Kirkwood; Tunde Peto; Usha Chakravarthy; Jayashree Ramu; Philip G Hykin; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6555.

ARVO Annual Meeting Abstract July 2019

Relative contributions of imaging markers of poor visual acuity in retinal vascular diseases.

Piyali Sen; Joan Nunez Do Rio; Manjula Nugawela; Ahmed M Hagag; Philip G Hykin; Akanksha Bagchi; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1888.

ARVO Annual Meeting Abstract July 2019

Efficacy of Intravitreal Aflibercept Administered using Treat-and-Extend Regimen over 2 Years in Patients with Neovascular Age-Related Macular Degeneration: 1-Year ARIES Results.

Paul Mitchell; Eric H Souied; Edoardo Midena; Frank G Holz; Philip G Hykin; Sebastian Wolf; Helmut Allmeier

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):117.

Retina May 2019

The Relationship Between Retinal Vessel Oxygenation and Spatial Distribution of Retinal Nonperfusion in Retinal Vascular Diseases

PDF

Luke Nicholson; Clara Vazquez-Alfageme; Philip G. Hykin; James W. Bainbridge; Sobha Sivaprasad
TAGS: alveolar ventilation function, cell respiration, oximetry, retinal vascular disorders, retinal vessels
Invest. Ophthalmol. Vis. Sci.. 2019; 60(6):2083-2087. https://doi.org/10.1167/iovs.18-24917

Retina August 2018

Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY Substudy

PDF

Luke Nicholson; Roxanne Crosby-Nwaobi; Joana C. Vasconcelos; A. Toby Prevost; Jayashree Ramu; Amy Riddell; James W. Bainbridge; Philip G. Hykin; Sobha Sivaprasad
TAGS: aflibercept, panretinal photocoagulation, proliferative diabetic retinopathy, eye, oximetry
Invest. Ophthalmol. Vis. Sci.. 2018; 59(10):4277-4284. https://doi.org/10.1167/iovs.17-23509

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2018

A Multicentre Double-masked Randomised Controlled Non-Inferiority Trial comparing clinical and cost effectiveness of intravitreal therapy with ranibizumab (Lucentis) vs aflibercept (Eylea) vs bevacizumab (Avastin) for Macular Oedema due to Central Retinal Vein Occlusion [LEAVO]: Baseline patient sociodemographic and ocular characteristics.

Philip G Hykin; Joana Vasconcelas; Toby Prevost; Sobha Sivaprasad; Barry Hounsome; Usha Chakravarthy; Simon Harding; Andrew Lotery; Yit C. Yang; Piyali Sen; Jayashree Ramu; Luke Nicholson; Tunde Peto

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2569.

ARVO Annual Meeting Abstract June 2017

Three-Year Real World Outcomes of Aflibercept Treatment of Treatment-naïve Patients with Neovascular Age-related Macular Degeneration

Maria Eleftheriadou; Maria K Gemenetzi; Sobha Sivaprasad; Philip G Hykin; Robin Hamilton; Adnan Tufail; Praveen J Patel

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):874.

ARVO Annual Meeting Abstract June 2017

Clinical, optical coherence tomography and fundus autofluorescence findings in atrophic maculopathy associated with pseudoxanthoma elasticum

Panagiotis Vasilopoulos; Andrew R Webster; Catherine A Egan; Hemal Mehta; Philip G Hykin

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4639.

ARVO Annual Meeting Abstract June 2017

The distribution of macular pigment in different macular diseases

Roy Schwartz; Roxanne Crosby-Nwaobi; Adam M Dubis; Philip G Hykin; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4818.

ARVO Annual Meeting Abstract June 2015

Correlation of retinal sensitivity with retinal thickness and morphological features of diabetic macular oedema

Oliver Comyn; Rishma Gohil; Praveen J Patel; James W B Bainbridge; Philip G Hykin; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1733.

ARVO Annual Meeting Abstract June 2015

A prospective randomised controlled clinical trial comparing a combination of repeated intravitreal Ozurdex and macular laser therapy versus macular laser monotherapy in centre-involving diabetic macular edema (OZLASE study).

Ling Zhi Heng; Sobha Sivaprasad; Roxanne R Crosby-Nwaobi; Zubin Saihan; Michael Kerampelas; Catey Bunce; Tunde Peto; Philip G Hykin; OZLASE

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1746.

ARVO Annual Meeting Abstract June 2015

The sensitivity and specificity of disorganisation of the retinal inner layers on SD-OCT in detecting capillary nonperfusion in diabetic retinopathy

Luke Nicholson; Jayashree Ramu; Ioanna Triantafyllopolou; Namritha Valerie Patrao; Oliver Comyn; Philip G Hykin; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5940.

ARVO Annual Meeting Abstract June 2015

Real-world outcomes of Ranibizumab treatment for Diabetic Macular Oedema

Namritha Valerie Patrao; Sheelah Antao; Dawn A Sim; Sobha Sivaprasad; Richard Andrews; Robin Hamilton; Catherine A Egan; Adnan Tufail; Philip G Hykin; Ranjan Rajendram

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3148.

ARVO Annual Meeting Abstract June 2015

Disease outcome in central serous chorioretinopathy patients with and without treatment

Jayashree Ramu; Luke Nicholson; Mahdi Muwas; Philip G Hykin; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3727.

ARVO Annual Meeting Abstract June 2015

Real-world UK NHS outcomes of a switch to Aflicercept from Ranibizumab in Neovascular age related macular degeneration (nvAMD).

Maria Cristina Citu; Roxanne R Crosby-Nwaobi; Philip G Hykin; Robin Hamilton; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4582.

ARVO Annual Meeting Abstract June 2015

Real-world rapid mean visual acuity improvement in patients initiated on aflibercept therapy for treatment-naïve neovascular age-related macular degeneration (nAMD).

Roxanne R Crosby-Nwaobi; Philip G Hykin; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4605.

ARVO Annual Meeting Abstract April 2014

In vivo Adaptive Optics Retinal Imaging in Ischaemic Diabetic Maculopathy

Nick Muthiah; Sobha Sivaprasad; Pearse Andrew Keane; Joe Zhong; Philip G Hykin; Pete Coffey; Lyndon Da Cruz

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1587.

ARVO Annual Meeting Abstract April 2014

Response of visual function to multiple xanthophyll supplementation in patients with retinal diseases.

Roxanne R Crosby-Nwaobi; Kanom Bibi; Tunde Peto; Philip G Hykin; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3483.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Efficacy of Intravitreal Aflibercept Treat-and-Extend Regimen Over 2 Years for Neovascular Age-Related Macular Degeneration: ARIES Study

Comparison of treat-and-extend (T&E) dosing regimens and visual outcomes in the ARIES and ALTAIR studies of intravitreal aflibercept (IVT-AFL) in neovascular age-related macular degeneration (nAMD)

Treatment response based on topography of retinal neovascularization in proliferative diabetic retinopathy

Relative contributions of imaging markers of poor visual acuity in retinal vascular diseases.

Efficacy of Intravitreal Aflibercept Administered using Treat-and-Extend Regimen over 2 Years in Patients with Neovascular Age-Related Macular Degeneration: 1-Year ARIES Results.

The Relationship Between Retinal Vessel Oxygenation and Spatial Distribution of Retinal Nonperfusion in Retinal Vascular Diseases

Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY Substudy

Three-Year Real World Outcomes of Aflibercept Treatment of Treatment-naïve Patients with Neovascular Age-related Macular Degeneration

Clinical, optical coherence tomography and fundus autofluorescence findings in atrophic maculopathy associated with pseudoxanthoma elasticum

The distribution of macular pigment in different macular diseases

Correlation of retinal sensitivity with retinal thickness and morphological features of diabetic macular oedema

A prospective randomised controlled clinical trial comparing a combination of repeated intravitreal Ozurdex and macular laser therapy versus macular laser monotherapy in centre-involving diabetic macular edema (OZLASE study).

The sensitivity and specificity of disorganisation of the retinal inner layers on SD-OCT in detecting capillary nonperfusion in diabetic retinopathy

Real-world outcomes of Ranibizumab treatment for Diabetic Macular Oedema

Disease outcome in central serous chorioretinopathy patients with and without treatment

Real-world UK NHS outcomes of a switch to Aflicercept from Ranibizumab in Neovascular age related macular degeneration (nvAMD).

Real-world rapid mean visual acuity improvement in patients initiated on aflibercept therapy for treatment-naïve neovascular age-related macular degeneration (nAMD).

In vivo Adaptive Optics Retinal Imaging in Ischaemic Diabetic Maculopathy

Response of visual function to multiple xanthophyll supplementation in patients with retinal diseases.

To View More...

You must be signed into an individual account to use this feature.